MELT — Melt Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Melt Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 2.93 | 11.3 |
| Prepaid Expenses | ||
| Total Current Assets | 2.96 | 11.3 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.002 | 0 |
| Total Assets | 2.96 | 11.3 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 1.34 | 15.7 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 1.56 | 16 |
| Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 1.4 | -4.67 |
| Total Liabilities & Shareholders' Equity | 2.96 | 11.3 |
| Total Common Shares Outstanding |